Top Industry Leaders in the Hyperpigmentation Disorders Treatment Market
Latest Hyperpigmentation Disorders Treatment Companies Updates:
Galderma announces positive Phase 2b results for its KP105 topical cream: This novel cream targeting moderate-to-severe melasma demonstrates significant improvements in skin lightening and reducing hyperpigmentation compared to placebo.
L'Oréal partners with MitoBiogen to develop new ingredients: This collaboration focuses on creating innovative active ingredients for cosmetic products based on MitoBiogen's expertise in mitochondrial biology and skin pigmentation.
Valeant acquires Medicis Aesthetics: This $2.6 billion deal in December 2023 strengthens Valeant's position in the dermatology market by adding Medicis' portfolio of hyperpigmentation treatment products.
Johnson & Johnson launches new SkinCeuticals Pro Peel system: This professional-grade chemical peel system specifically targets hyperpigmentation concerns, offering customized treatment options in dermatologist offices.
American Academy of Dermatology (AAD): Provides information and resources on skin conditions, including hyperpigmentation disorders.Skin of Color Society (SOCS): Advocacy organization dedicated to addressing the unique needs of skin of color patients, including hyperpigmentation concerns.
List of Hyperpigmentation Disorders Treatment Key companies in the market:
- Allergan
- Bayer AG
- EpiPharm AG
- Episciences
- Galderma laboratories (Nestle Skin Health S.A)
- Obagi Cosmeceuticals LLC
- Pierre Fabre
- RXi Pharmaceuticals Corporation
- SkinCeuticals International